Cathy Anne Pinto

7PUBLICATIONS
23CO-AUTHORS
Liquid biopsiesPharmacogenomicsPredictive and prognostic markersPersonality and individual differencesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 11, 2026
Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.

W Marston Linehan, Thomas Jemielita, Jerry Cornell

|Dec 12, 2023
Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey.

Cathy Anne Pinto, Tommi Tervonen, Cecilia Jimenez-Moreno

|Sep 16, 2022
Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma.

Frede Donskov, Cathy Anne Pinto, Raluca Predoiu

|Dec 06, 2021
Treatment and overall survival among anti-PD-1-exposed advanced melanoma patients with evidence of disease progression.

Cathy A Pinto, Xinyue Liu, Xiaoyun Li

|Sep 27, 2021
Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment.

Cathy Anne Pinto, Gin Nie Chua, John F P Bridges

|Jun 28, 2021
Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference Studies.

Selena Russo, Dario Monzani, Cathy Anne Pinto

Pageof 2

Frequent Collaborators

3 joint publications

Tommi Tervonen

1 joint publications

Xinyue Liu

1 joint publications

Xiaoyun Li

1 joint publications

Emilie Scherrer